BRIDGEWATER, NJ--(Marketwire - May 05, 2008) - Alpharma Inc. (NYSE: ALO), a global specialty pharmaceutical company, today announced first quarter 2008 diluted earnings per share ("EPS") of $3.77. First quarter 2008 results include EPS of $4.67 related to the Active Pharmaceuticals Ingredients ("API") business and its sale to 3i (LSE: III) for $395 million. The API sale closing occurred on April 1, 2008, with the transaction effective as of the close of business on March 31, 2008. The API business is being reported as a discontinued operation.
